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Abstract
Background: Although cystitis in women is very common in general practice, its evolution in symptoms has not
been clearly studied. Qualitative research has pointed to other than the classic symptomatology.
Methods: This was a prospective observational study of the symptomatology at presentation and the evolution
of the symptoms in treated women with suspected uncomplicated urinary tract infection (UTI). Women con-
sulting their general practitioner (GP) for dysuria, urgency, or frequency produced a urine sample (for bacte-
riologic processing) and kept a diary until the end of the symptoms. Exclusion criteria included complaints > 1
week, fever, vaginal discharge, and known pathology.
Results: Of the 300 asked to participate, 148 (49%) returned the diary. Although none of the patients developed
acute pyelonephritis, a substantial number of the women had such complaints as feeling feverish (33% in
culture-positive group, 38% in culture-negative group), back pains (44% vs. 56%), and feeling weak and tired
(71% vs. 65%). Differences between the culture-positive and culture-negative groups were not statistically sig-
nificant except for the duration of symptoms, which was shorter in the culture-positive group (4 vs. 6 days).
More severe symptoms at inclusion were correlated with a longer duration of these symptoms.
Conclusions: The spectrum of complaints in women with suspected uncomplicated UTI is broad and comprises
a number of symptoms usually associated with an upper UTI. The occurrence of these symptoms should not
automatically prompt GPs to prescribe broad-spectrum antibiotics. Moreover, the duration of symptoms ex-
ceeding the recommended duration of antibiotic therapy does not indicate therapy failure and, thus, the need for
changing antibiotic therapy.
Introduction
Physicians often consider an uncomplicated urinarytract infection (UTI) in otherwise healthy women as a
trivial and well-known condition characterized by a limited
number of complaints (dysuria, urgency, frequency), which is
rapidly resolved with a 3-day treatment.1,2 Research based on
patients’ experiences, however, mentions a broad range of
symptoms,3,4 and although UTI is the most common infec-
tious disease in adult women, the course of these symptoms is
not well documented. Correct information about the symp-
toms and their average duration is important to reassure the
patient and to avoid unnecessary reconsultation, referrals, or
changes in treatment, such as a switch to broad-spectrum
antibiotics. Furthermore, although a bacterial culture of
> 100,000 colony-forming units (CFU)/mL is generally ac-
cepted as defining an infection of the urinary tract, many
authors describe the same symptoms in patients with lower
levels of bacteriuria and even in culture-negative women.4–7 It
has even been suggested that antibiotic therapy was effective
in culture-negative women.8
These conflicting observations demonstrate that much is
unclear about the clinical evolution of signs and symptoms in
womenwith suspected cystitis who are receiving antimicrobial
treatment. This study explored the clinical course of various
symptoms, their duration, and the factors that may influence
the duration in patients consulting their general practitioner
(GP) with complaints suggestive of an uncomplicated UTI.
Materials and Methods
Participating GPs and patients
Between November 2004 and March 2006, we performed
an observational study. Sixty-six GPs in 28 practices in the
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region of Ghent were asked to include all female patients ‡ 18
years of age presenting with complaints of dysuria, urgency,
frequency. Patients with symptoms of complicated UTI at
presentation (symptoms lasting longer than 7 days, axillary
temperature > 38C) or predisposing factors (pregnancy,
known urologic or nephrologic problems, diabetes mellitus,
other immunocompromising diseases), patients with recur-
rent UTI (more than three occurrences in the last year), and
patients who had received antibiotics during the past 4 weeks
or had obvious gynecologic complaints (abnormal discharge,
labial irritation, intermittent vaginal blood loss, and vaginal
itch) were excluded.
Data collection
At the first visit, the GP recorded the patient’s age and
reason for the encounter. Patients were asked to complete a
questionnaire about their personal characteristics and to keep
a diary about the evolution of their symptoms. The items in
the diary were based on qualitative research performed by
Malterud and Baerheim3 in 1994 and on a cross-sectional
observational study in 2003, exploring the symptoms experi-
enced by women with a lower UTI.3,4 All items that occurred
in > 1 in 3 diaries were retained as scoring categories for the
diary. Impact on daily life was also registered. Patients were
asked to score symptoms daily on a three-step categorical
scale of 0 = absent, 1=moderately severe, 2= very severe.
Statistics
Data were analyzed using SPSS 12 (Chicago, IL). A com-
parison of proportions was performed using the chi-square
test. Correlation statistics were used to assess the association
between culture growth and the severity of symptoms. Sur-
vival analysis was used to both describe the duration of
symptoms and explore the influence of various factors on this
duration. To assess the correlation between the presence of
symptoms and the duration of complaints, symptom severity
scores were dichotomized.
Ethical approval
All patients received written information about the study
and gave written informed consent. The study was approved
by the ethical committee of the University Hospital Ghent.
Results
Population
Three hundred women were included, of whom 148 (49%)
returned the diary. Thirteen patients received no therapy and
were excluded from our analysis to avoid bias resulting from
differences in management. One hundred thirty-five patients
received antibiotic therapy (Fig 1). The patients were between
17 and 80 years old, with a mean age of 41.7 years (standard
deviation [SD] 17.1). The average duration of the antimicro-
bial treatment was 4.68 days ( SD 2.16, median 4). None of the
participants underwent antibiotic therapy > 10 days. Ni-
trofuranes were prescribed most frequently (72.8%), 11% of
the women took fluorochinolone, and 2 women did not take
the prescribed antibiotic.
Participating and nonparticipating women had the same
distribution of reasons for seeking healthcare. Participating
women had a higher rate of positive cultures (68.7% vs. 57%,
chi-square, p< 0.05) and a higher mean age (41.4 years vs. 35.4
years, p< 0.01). As 30% of our patients had no positive culture
growth, we refer to our study population as women with
suspected uncomplicated UTI.
Symptoms
Symptoms were categorized as voiding related, local, or
generalized symptoms.4 All voiding symptoms, with the ex-
ception of incontinence, were highly prevalent, as expected.
Apart from the typical voiding symptoms, however, a sub-
stantial number of women also had local and generalized
symptoms at day 1 (Table 1). Suprapubic pressure, feeling
feverish, or feeling weak and tired were very common, al-
FIG. 1. Flow diagram of included and excluded patients.
Table 1. Frequency of Each Symptom
on Days 1, 3, 5, and 7
Day 1 Day 3 Day 5 Day 7
na + b % % % %
Voiding symptoms
Dysuria 110 103 93.6 56.7 25.0 15.7
Continuous needc 108 98 90.7 52.4 13.0 8.0
Frequency 105 90 85.7 30.7 6.6 10.0
Urge 106 97 91.5 58.3 19.8 14.0
Incontinence 106 40 37.7 20.2 4.4 2.0
Local symptoms
Suprapubic pressure 107 80 74.8 37.9 19.6 8.2
Pressure in genital area 107 66 61.7 29.8 15.2 10.2
Low back pain 107 52 48.6 27.9 15.4 14.0
General symptoms
Unwell 107 57 53.3 14.4 2.2 2.0
Weak and tired 107 74 69.2 33.7 14.3 12.2
Irritable and restless 106 51 48.1 18.3 5.5 4.1
Feverish 105 37 35.2 7.8 5.6 0
an, total of patients completing item.
b+ , number of patients with symptom.
cContinuous need, a feeling of a continuous need to void.
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though none of the participants developed an acute pyelo-
nephritis during the 14-day follow-up period.
Bacterial culture and clinical symptoms
No difference in individual symptoms at presentation was
found between culture-positive and culture-negative women
(Table 2). These findings were independent of the cutoff value
used to define positive culture growth: 105, 104, or 103 CFU/
mL. No correlation was found between bacteriuria and the
severity of symptom scores.
Duration of symptoms
The median duration until disappearance of all symptoms
was 4 days (95% Confidence interval [CI] 3-5) (Fig 2). When
considering the three symptom categories separately with
survival analysis, we found a median duration of 4 days for
voiding symptoms, 3 days for local symptoms, and 2 days for
generalized symptoms (Fig. 3). This difference in duration
was significant (log rank, p< 0.005). Women with a positive
culture (105 CFU/mL) experienced complaints for a shorter
period (median duration: > 105: 4 days vs. < 105: 6 days; log
rank, p= 0.0275). This was also the case when using 103CFU/
mL as a cutoff level for positive culture growth4 (median
duration: 4 days vs. 7 days; log rank, p= 0.0380).
There was no significant difference in the duration of
symptoms between younger and older women (< 55 and > 55
years) (log rank, p= 0.987). The duration of symptomswas not
related to the length of antibiotic treatment, neither when
considering all treatments nor when considering the sub-
group of patients taking nitrofuranes (73%) (log rank: 3-day
therapy, p = 0.3452; 5 days, p= 0.2455; 7days, p = 0.5259).
A higher severity score of each voiding symptom at first
presentation was correlated with a longer duration of the re-
spective symptom (log rank: dysuria, feeling of a continuous
need to void, frequency, incontinence, p< 0.005; urge,
p = 0.0413). This was also the case for the different categories of
symptoms. (log rank: voiding symptoms, p = 0.0034; local
symptoms, p= 0.0065; generalized symptoms, p= 0.0034). Si-
milar results were found for the overall severity score of all
symptoms.
Discussion
Main findings
The majority of women with suspected uncomplicated UTI
experience a number of general symptoms besides the typical
voiding symptoms, which is usually considered as indicative
of an upper UTI. The median duration of these symptoms is 4
days, which means that 50% of the patients will experience
complaints after finishing antibiotic treatment.1,2 A higher
symptom severity score is correlated with longer duration of
the complaints. Finally, positive culture growth predicts a
shorter duration of symptoms. No correlation has been found
between the extent of bacteriuria at inclusion and the nature of
the symptoms and the severity of the symptoms.
A broad range of symptoms
The literature has previously mentioned that women with
uncomplicated UTI suffer from a broad range of symptoms.3,4
Our study further substantiates this finding by adding data of
a 14-day follow-up period after inclusion. Generalized
symptoms, even when present for several days, do not nec-
essarily indicate an upper UTI; they are very common in acute
uncomplicated lower UTI. During the follow-up, none of the
womenwith generalized symptoms developed an upper UTI,
although most women were treated with nitrofuranes, which
are only proposed for use in lower UTIs. Clinicians should be
aware that patients feeling unwell, feverish, or weak do not
necessarily have a complicated UTI. General symptoms do
not differentiate between lower and upper UTI.
Bacterial culture and clinical symptoms
No correlation was found between bacteriuria and the type
of symptoms or symptom scores. Bent et al.9 conclude that in
Table 2. Frequency of Symptoms on Day 1 in Negative and Positive Cultures (105)
Positive culture Negative culture
% + a n + b + c % + a n - d + c
Difference
in proportions %e p valuef
Dysuria 96 75 72 91.2 34 31 4.8 0.373
Continuous needg 91.8 73 67 88.2 34 30 3.6 0.723
Frequency 84.5 71 60 87.9 33 29 - 3.4 0.770
Urge 91.5 71 65 94.1 34 32 - 2.6 1.000
Incontinence 38 71 27 38.2 34 13 - 0.2 1.000
Suprapubic pressure 72.2 72 52 79.4 34 27 - 7.2 0.483
Pressure in genital area 59.7 72 43 64.7 34 22 - 5.0 0.674
Low back pain 44.4 71 32 55.9 34 19 - 11.5 0.303
Unwell 55.6 72 40 47.1 34 16 8.5 0.532
Weak and tired 70.8 72 51 64.7 34 22 6.1 0.654
Irritable and restless 46.5 71 33 50 34 17 - 3.5 0.835
Feverish 32.9 70 23 38.2 34 13 - 5.3 0.662
a% + , % of culture-positive women.
bn + , number of culture-positive women.
c+ , number with specific complaint.
dn- , number of culture-negative women.
e(% positive culture) - (% negative culture).
fFisher’s exact test.
gContinuous need, a feeling of a continuous need to void.
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women with one or more symptoms of a UTI, the probability
of an infection is approximately 50%, but that specific com-
binations of symptoms (dysuria and frequency without vag-
inal discharge or irritation) increase the probability of UTI
substantially (to 90%), thus making it possible to base the
diagnosis on the history alone. In our study, women with
vaginal symptoms were excluded. According to the conclu-
sion of Bent et al., 90% of the patients included in our study
would be expected to have bacteriuria, whereas only 70% had
positive cultures.
Conversely, our results confirm the findings of Ferry
et al.,10 who also found no correlation between symptoms and
symptom scores at inclusion, on the one hand, and bacteri-
uria, bacterial counts, or species on the other. Likewise Baer-
heim et al.4 could not show any differences in frequency or in
the pattern of the symptoms between patients with or without
bacteriuria. Recently, Little et al.11 found only 64.2% positive
bacteriuria in women with suspected UTI, which is very
similar to our results.
Nevertheless, GPs are more inclined to treat patients with
antibiotics when certain specific symptoms are present, that
is, frequency and dysuria or dysuria alone (Fahey et al.12). As
some studies show that these symptoms do not substantially
increase the posttest probability of a positive growth culture, a
discussion has started in the literature debating the value of
individual UTI symptoms for diagnostic testing and treat-
ment in primary care. Our findings support the position that
individual symptoms are not very helpful in predicting bac-
teriuria.
Duration of symptoms
Overall, the median duration of the complaints was 4 days.
This is in agreement with other studies (Ferry et al.13: duration
4 days). Four days after presentation, 50% of the women still
have symptoms. Consequently, clinicians should be careful in
promising quick relief of symptoms when prescribing anti-
biotics. Doctors and patients may be inclined to change or
continue the treatment at the end of a 3-day antibiotic course
because of ongoing complaints, although this is not an indi-
cation of treatment failure.
We found two factors that influenced the duration of
symptoms. First, more severe complaints at presentation last
longer. To our knowledge, it is the first time that this relation
between severity and duration has been investigated, and this
may be important to clinicians when informing their patients
about the expected course of their complaints. Second, a
positive culture is correlated with a shorter duration of
symptoms. A possible explanation is that the antibiotic ther-
apy all patients in our study were given may be ineffective in
women with symptoms of UTI but who have a negative cul-
ture. These correlations were independent of the cutoff for
bacterial culture growth used. This finding adds to the on-
going discussion about the most appropriate cutoff value.5,6
Strengths and limitations
To our knowledge, this is the first study investigating the
correlation between the severity of symptoms or bacteriuria
and the duration of symptoms. The design of the diary was
based on previous qualitative and cross-sectional research to
maximize its validity.3,4 A rather high rate of 49% of eligible
patients returned their diaries. The diaries returned were of
good quality: almost 75% of the participating women filled
out each item each day.
The participants were on average older and more fre-
quently had a positive bacterial culture. It is unlikely that the
age difference caused any bias, as we found no correlation
FIG. 2. Duration (days) of all symptoms (voiding, local,
and generalized). + , censored.
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FIG. 3. Duration (days) of voiding (solid line), local (dashed
line), and generalized (dotted line) symptoms. + , censored.
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between age and duration. The number of patients included
was smaller than expected; participating GPs reported that
this was mainly due to lack of time and the complexity of the
protocol. As the study did not interfere with the treatment, it
is unlikely that any bias occurred as a result of selection or
exclusion of patients with specific clinical characteristics.
Conclusions
During a follow-up period of 14 days, the majority of wo-
men with suspected uncomplicated UTI symptoms also re-
ported a number of other complaints, apart from the typical
voiding symptoms. General symptoms, such as feeling fe-
verish, back pains, and feeling sick—traditionally considered
as indicative of an upper UTI—are very common in women
with suspected uncomplicated UTI, even when the bacterio-
logic culture is negative. This is an important finding con-
sidering that these symptoms will often prompt GPs to start
broad-spectrum antimicrobials, such as fluorochinolones,
which may cause unnecessary side effects and the emergence
of bacterial resistance. The fact that patients still experience
symptoms after finishing treatment does not require modifi-
cation nor continuation of the treatment. It is interesting for
patients who have more severe symptoms at presentation to
know that they are likely to experience these complaints for a
longer duration, yet it should not lead to a change in therapy.
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